42X is the most advanced asset & will start making some noise very soon with a phase 2/3 clinical trial in the USA. This asset is shaping up to be worth a lot of money. eg billions & billions.
However with the pace psychedelics is moving world wide - first revenues will come from the delivery of emerging psychedelic drugs - eg other companies drugs... “We initially intended to use only ketamine-assisted psychotherapy, with the possibility of expanding into psilocybin-assisted
psychotherapy for Generalised Anxiety Disorder subject to regulatory approval" Peter Widdows, Incannex Director and psychedelic clinics business lead.
Incannex are setting clinics up to be the service provider & one stop shop for all drug developers who are developers and not therapy service providers.
These clinics have the potential to be as big as anything else the company has going on.
42X is the most advanced asset & will start making some noise...
-
- There are more pages in this discussion • 4,171 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)